Clinicians should be aware of proton pump inhibitor–related changes in the gastric mucosa

키워드

참고문헌 (9)

1. Nocon M, "Long-term treatment of patients with gastro-oesophageal reflux disease in routine care : results from the ProGERD study", Aliment Pharmacol Ther, 25, pp.715~722 (2007)
2. Joel A, "Endoscopic radiofrequency Stretta therapy reduces proton pump inhibitor dependency and the need for anti-reflux surgery for refractory gastroesophageal reflux disease", Clin Endosc, 57, pp.58~64 (2024)
3. Welsch L, "Bile acid sequestrants in poor healing after endoscopic therapy of Barrett's esophagus", Clin Endosc, 56, pp.194~202 (2023)
4. Kim GH, "Proton pump inhibitor-related gastric mucosal changes", Gut Liver, 15, pp.646~652 (2021)
5. Haruma K, "Kyoto classification of gastritis" (2019), Nihon Medical Center
6. Hatano Y, "Factors associated with gastric black spot, white flat elevated mucosa, and cobblestone-like mucosa : a cross-sectional study", Digestion, 98, pp.185~193 (2018)
7. Majima K, "Multiple white and flat elevated lesions observed in the stomach : a prospective study of clinical characteristics and risk factors", Intern Med, 57, pp.2613~2619 (2018)
8. Hasegawa R, "Association between occurrence of multiple white and flat elevated gastric lesions and oral proton pump inhibitor intake", Clin Endosc, 57, pp.65~72 (2024)
9. Uedo N, "Multiple white flat lesions in the gastric corpus are not intestinal metaplasia", Endoscopy, 49, pp.615~616 (2017)

관련 논문AI추천